MiMedx Group Inc Share Price Nasdaq
Equities
US6024961012
Biotechnology & Medical Research
Sales 2024 * | 361M 28.87B | Sales 2025 * | 406M 32.44B | Capitalization | 1.1B 87.82B |
---|---|---|---|---|---|
Net income 2024 * | 45M 3.59B | Net income 2025 * | 55M 4.39B | EV / Sales 2024 * | 3.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.71 x |
P/E ratio 2024 * |
23.8
x | P/E ratio 2025 * |
18
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.76% |
Latest transcript on MiMedx Group Inc
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 60 | 26/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 04/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 01/07/20 |
Phyllis Gardner
BRD | Director/Board Member | 73 | 07/03/21 |
K. Newton
BRD | Director/Board Member | 61 | 18/06/19 |
1st Jan change | Capi. | |
---|---|---|
-22.03% | 126M | |
+3.72% | 75.91M | |
+5.15% | 60.02M | |
-1.20% | 51.7M |